Want a Free Job Posting?

Buy a job posting today and the second one is on us. For a limited time only. Act Now.

Oxford BioMedica Overview

Unlock Profile
Headquarters Oxford, United Kingdom
Size 51 to 200 Employees
Founded Unknown
Type Company - Public (OXB)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (USD) per year
Competitors Targeted Genetics, TRANSGENE, Antigenics
Oxford BioMedica has no reservations about launching attacks on disease. The biotechnology company uses gene therapy and immunotherapy to develop treatments for cancer, as well as neurodegenerative and ocular diseases. Its four ocular gene therapies are partnered with Sanofi ... More

Oxford BioMedica Reviews

Recommend to a friend
Approve of CEO
Oxford BioMedica CEO and Director John Dawson
John Dawson
0 Ratings
  • Helpful (2)

    Exiting prospects.

    Former Employee - Anonymous Employee
    Former Employee - Anonymous Employee


    Great people and facilities. Exciting product pipeline from many angles. Takes time out to celebrate and reward staff. Opportunity to work on genuinely important and interesting topics of your into bioscience and biomanufacturing.


    Quite a lot of bureaucracy. No real onboarding structure other than basic health and safety. Management not transparent. Slow pace of work. I didn't personally connect with the culture there but others seemed to enjoy the atmosphere.

    Advice to Management

    If you want to recruit and retain talent invest in people early, give them exciting work and provide some useful structure. Otherwise you're self selecting hires who will put up with average performance and slow progress.

Oxford BioMedica Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Work at Oxford BioMedica? Share Your Experiences

Oxford BioMedica

Click to Rate